Celera/Gemini Collaborate in Disease Gene Hunt

October 1999
Worldwide Biotech;Oct99, Vol. 11 Issue 10, p6
Trade Publication
Reports that Celera Genomics and Gemini Research limited have entered a collaboration to discover genes and genetic polymorphisms associated with common, chronic, age-related diseases. Terms of the agreement; How Celera and Gemini intend to commercialize the jointly owned results of the collaboration; Remarks from J. Craig Venter, president and chief scientific officer of Celera.


Related Articles

  • CWRU, Clinic researchers gain access to genetic data. Santiago, Raquel // Crain's Cleveland Business;8/6/2001, Vol. 22 Issue 32, p9 

    Reports the approval of a negotiation agreement for the access of researchers to the human gene system of Celera Genomics in Cleveland, Ohio. Contents of the agreement; Advantages in using the human gene system; Identification gene mutations through data information.

  • CELERA GENOMICS REPORTS $20.3 MILLION 2ND QTR REVENUES.  // Biotech Financial Reports;Mar2001, p1 

    Reports on the financial performance of Rockville, Maryland-based Celera Genomics Group for its second fiscal quarter ended December 31, 2000. Increase in revenues; Net loss after benefit for taxes; Research and development expenditures; Company history.

  • CELERA EXPANDS GENOMIC PROGRAM.  // Online Product News;Mar2002, pN.PAG 

    Deals with the announcement of Celera Genomics that Serono SA has signed a multi-year subscription agreement with its proprietary genomic databases. Significance of the deal to Celera; Information on Serono; Information on Celera parent Applera Corp.

  • Combining Informatics With Ingenuity. Janssen, Deborah // Genomics & Proteomics;Apr2002, Vol. 2 Issue 3, p18 

    Focuses on the expansion of Celera Genomics in the arena of drug discovery in Rockville, Maryland. Company background of Celera; Product and services offerings of the firm; Involvement of Celera to an extensive single nucleotide polymorphism program. INSETS: A Computer Powerhouse;The $10...

  • Human genome 90% done. Grisham, Julie // Nature Biotechnology;Feb2000, Vol. 18 Issue 2, p133 

    Reports on the announcement made by biotechnology company Celera Genomics Corp. on January 10, 2000 that it had completed the sequence for 90 percent of the human genome. Increase in the share prices of the company after the announcement; Tasks to be taken up by the company after the completion...

  • Rules of genome access.  // Nature;3/23/2000, Vol. 404 Issue 6776, p317 

    Examines the question of whether raw data from human genome projects should be released rapidly into the public domain. Actions taken by biotechnology firm Celera Genomics which might undermine efforts to avert a monopolistic hold on human genome databases; Recommendation that human sequence...

  • Genome debate continues. Grisham, Julie // Nature Biotechnology;May2000, Vol. 18 Issue 5, p475 

    Reports on the debate between the two working groups working to complete the sequence of human genome which is reported to have begun on April six 2000 following Rockville, Maryland-based Celera Genomics Corp.'s announcement of the completion of the genome sequencing of one person. Time...

  • Celera in talks to launch private sector human proteome project. Butler, Declan // Nature;2/24/2000, Vol. 403 Issue 6772, p815 

    Reports on the plans of Celera Genomics to launch its Human Proteome Project in an attempt to identify the properties and functions of every protein expressed in an organism. Negotiations of Celera with Denis Hochstrasser, one of the founders of GeneBio; Technology to be used for the project.

  • Getting it together.  // Nature Biotechnology;Jul2000, Vol. 18 Issue 7, p693 

    Reports that Human Genome Project and Celera Genomics Corp. are about to complete a working draft of the sequence of the human genome as of July 18, 2000. Reasons for the delay in completion of the project; Need to resolve differences between companies and collaborate for producing the final draft.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics